Literature DB >> 23930970

Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease.

Ramandeep Kaur1, Kawaljit Matharoo, Punit Arora, A J S Bhanwer.   

Abstract

AIMS: Inflammatory markers play an important role in the development of diseases related to metabolic syndrome, such as type 2 diabetes (T2D) and coronary artery disease (CAD). The present study evaluates the association of -2518A>G polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with T2D and CAD.
RESULTS: The frequency of the G allele is greater in CAD cases (35%) as compared to T2D (24.6%) and controls (31%), while the frequency of the A allele is higher in T2D cases (75.4%) as compared to CAD cases (65%) and controls (69%). The analysis has revealed that in comparison to T2D cases, the G allele increases the risk of CAD by 1.9-fold (p=0.008; odds ratio [OR]=1.9, 1.18-3.06 at 95% confidence interval [CI]) but in comparison to controls the G-allele provided protection against T2D (p=0.011; OR=0.55, 0.35-0.87 at 95% CI), both under the dominant model (AG+GG vs. AA).
CONCLUSION: Results of the present study suggests that G-allele of MCP-1 -2518A>G polymorphism is associated with reduced risk of T2D and increased risk of CAD in the population of Punjab. The results indicate that there is a difference in the association of risk alleles with phenotypes of metabolic syndrome. Body mass index and waist circumference are important risk factors for T2D in the population of Punjab.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23930970      PMCID: PMC3780327          DOI: 10.1089/gtmb.2013.0227

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  37 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Which method should be used to determine the obesity, in patients with coronary artery disease? (body mass index, waist circumference or waist-hip ratio).

Authors:  K Sönmez; M Akçakoyun; A Akçay; D Demir; N E Duran; M Gençbay; M Degertekin; F Turan
Journal:  Int J Obes Relat Metab Disord       Date:  2003-03

5.  The MCP-1 -2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population.

Authors:  M Bucova; J Lietava; F Mrazek; J Petrkova; P Penz; M Bernadic; T A Buckingham; M Petrek
Journal:  Bratisl Lek Listy       Date:  2009       Impact factor: 1.278

Review 6.  C-reactive protein: risk marker or mediator in atherothrombosis?

Authors:  Ishwarlal Jialal; Sridevi Devaraj; Senthil K Venugopal
Journal:  Hypertension       Date:  2004-05-17       Impact factor: 10.190

7.  Association of serum MCP-1 concentration and MCP-1 polymorphism with insulin resistance in Japanese individuals with obese type 2 diabetes.

Authors:  Kunichi Kouyama; Kazuaki Miyake; Masako Zenibayashi; Yushi Hirota; Tetsuya Teranishi; Yoshikazu Tamori; Hajime Kanda; Kazuhiko Sakaguchi; Takeshi Ohara; Masato Kasuga
Journal:  Kobe J Med Sci       Date:  2008-02-08

8.  Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus.

Authors:  E Simeoni; M M Hoffmann; B R Winkelmann; J Ruiz; S Fleury; B O Boehm; W März; G Vassalli
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

9.  Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients.

Authors:  Riadh Jemaa; Hajer Rojbani; Amani Kallel; Samir Ben Ali; Moncef Feki; Sonia Chabrak; Monia Elasmi; Samah Haj Taieb; Haïfa Sanhaji; Omar Souheil; Rachid Mechmeche; Naziha Kaabachi
Journal:  Clin Chim Acta       Date:  2008-01-16       Impact factor: 3.786

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  4 in total

1.  Clinical impact of echocardiography parameters and molecular biomarkers in heart failure: Correlation of ACE2 and MCP-1 polymorphisms with echocardiography parameters: A comparative study.

Authors:  Mălina Suciu-Petrescu; Anamaria Truta; Mihai Domnutiu Suciu; Adrian Pavel Trifa; Denisa Petrescu; Horia Ștefan Roșianu; Octavia Sabin; Daciana Elena Popa; Antonia Eugenia Macarie; Ștefan Cristian Vesa; Anca Dana Buzoianu
Journal:  Exp Ther Med       Date:  2021-04-28       Impact factor: 2.447

2.  Association of monocyte chemoattractant protein-1-2518A/G polymorphism and risk of coronary artery disease among the Chinese population: a meta-analysis.

Authors:  Shuang Zuo; Honglin Wang; Benrong Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis.

Authors:  Binnur Bagci; Gokhan Bagci; Ferhan Candan; Ozturk Ozdemir; Ilhan Sezgin
Journal:  Int Urol Nephrol       Date:  2015-02-06       Impact factor: 2.370

4.  Monocyte chemoattractant protein-1 polymorphism interaction with spirulina immunomodulatory effects in healthy Korean elderly: A 16 week, double-blind randomized clinical trial.

Authors:  Hee Jung Park; Hyun Sook Lee
Journal:  Nutr Res Pract       Date:  2017-06-09       Impact factor: 1.926

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.